Nantomics Selected By Genomics England To Move To Next Stage Of 100,000 Genomes Project For Patients With Cancer

LONDON--(BUSINESS WIRE)--Dr. Patrick Soon-Shiong, Chairman and CEO of NantOmics, a member of the Nant family of companies, announced today that the company had been advanced to the next phase of Genomics England’s annotation assessment exercise. A team led by Tim Hubbard of King’s College, London and Head of Bioinformatics and Genomics England evaluated NantOmics’ response to the exercise, determining the current capabilities of NantOmics.

Help employers find you! Check out all the jobs and post your resume.